An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

The PET/MRI scan, a relatively new hybrid imaging method may increase the accuracy of cancer diagnoses, according to a study published in the journal Current Radiology Reports. Researchers from ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

The Case Comprehensive Cancer Center will host its next seminar series event Friday, Feb. 2, from noon to 1 p.m. in the Iris S. and Bert L. Wolstein Research Building auditorium. The event will ...

Carly Bartuccio talks with event attendees about the new PET-CT scanner at a ribbon-cutting. Nothing can replace the caring touch of a health care worker, nor the expert clinical decision-making of a ...

PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.